Novo Integrated Sciences CEO Mattacchione resigns effective Feb 20, 2025; stays Chairman

Novo Integrated Sciences, Inc.

Robert Mattacchione's resignation as CEO extended to Feb 20, 2025 for orderly transition.
He will remain Chairman of the Board and Chairman of subsidiary Novo Healthnet Limited.
No successor CEO has been appointed; board searching to fill vacancy.
Resignation is not due to any disagreement with the Company on operations or policies.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Robert Mattacchione

Chief Executive Officer

Novo Integrated Sciences, Inc.

Effective: 2025-02-20
Filed: February 11, 2025, 6:59 PM ET

on February 5, 2025, the Company and Mr. Mattacchione agreed to extend the effective date of Mr. Mattacchione’s resignation to February 20, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Mattacchione resigned as Chief Executive Officer at Novo Integrated Sciences, Inc..

Action: resigned
Role: Chief Executive Officer

Exact text from the filing

on February 5, 2025, the Company and Mr. Mattacchione agreed to extend the effective date of Mr. Mattacchione’s resignation to February 20, 2025

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-25-005923

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.